Nutritional Health

Diagnostics

Pain & Inflammation

Allergic Diseases and Allergy

Metabolic Disease

Infectious Disease

Antibiotic Alternatives

Immunology

Oncology

Peter Hanson

Chief Veterinary Officer and EVP Clinical Operations & CMC

Centrexion Therapeutics

Centrexion is developing a pipeline of non-opioid, non-addictive treatments to manage pain in people and animals.  Peter started his career as a practicing veterinarian and has spent the last 21 years in industry. At Merck and then Merial he was the project leader for two global programs that led to new pain management products for osteoarthritis in dogs and horses.  He subsequently held leadership roles for pharmaceutical R&D and project & portfolio management before moving to Abbott Animal Health where he was head of R&D & medical affairs.  Peter received his BA and DVM from the University of Minnesota and completed a large animal surgical residency, MS and PhD at the University of Wisconsin-Madison.